Dr. Ianelli is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
iSpecimen Inc.
450 Bedford Street
Lexington, MA 02420Phone+1 781-301-6698
Summary
- Dr. Christopher Ianelli is the Founder and CEO of iSpecimen Inc., headquartered in Lexington, MA. He received both his Ph.D. degree and M.D. degree from Tufts University School and completed training in laboratory medicine and pathology at Brigham & Women's Hospital. Dr. Ianelli has founded numerous companies and currently leads iSpecimen Inc. as its Founder and CEO.
Education & Training
Brigham and Women's HospitalResidency, Pathology-Anatomic and Clinical, 2000 - 2003- Brigham and Women's HospitalChief Residency, Pathology-Anatomic and Clinical, 2001 - 2002
Tufts University School of MedicineClass of 2000
Tufts University Sackler School of Biomedical SciencesPh.D., 1989 - 1996
Certifications & Licensure
MA State Medical License 2002 - 2012
Clinical Trials
- Collection and Distribution of Biospecimens for Novel Research Uses Start of enrollment: 2016 Jun 30
Publications & Presentations
PubMed
- 9 citationsFunction of CD48 and its regulation by Epstein-Barr virusDavid A. Thorley-Lawson, Christopher J. Ianelli, L D Klaman, Donald E. Staunton, Shinkichi Yokoyama
Biochemical Society Transactions. 1993-11-01 - 38 citationsSchistosoma mansoni: genetic restriction and cytokine profile of the CD4 + T helper cell response to dominant epitope peptide of major egg antigen Sm-p40.Hector J. Hernandez, C M Edson, Donald A. Harn, Christopher J. Ianelli, Miguel J. Stadecker
Experimental Parasitology. 1998-09-01 - 24 citationsCD48 Binds to Heparan Sulfate on the Surface of Epithelial CellsChristopher J. Ianelli, Ron DeLellis, David A. Thorley-Lawson
The Journal of Biological Chemistry. 1998-09-04
Press Mentions
3 Barriers to Advance Care Planning for Sexual and Gender Minority PeopleAugust 2nd, 2022- iSpecimen to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference on September 13-15, 2021September 1st, 2021
iSpecimen and Myonsite Healthcare Deploy Mobile Phlebotomy to Help Advance Research During the Coronavirus PandemicMay 21st, 2020- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
